140 related articles for article (PubMed ID: 17763059)
1. Gelatin microspheres cross-linked with EDC as a drug delivery system for doxycyline: development and characterization.
Adhirajan N; Shanmugasundaram N; Babu M
J Microencapsul; 2007 Nov; 24(7):647-59. PubMed ID: 17763059
[TBL] [Abstract][Full Text] [Related]
2. Studies on a novel gelatin sponge: preparation and characterization of cross-linked gelatin scaffolds using 2-chloro-1-methylpyridinium iodide as a zero-length cross-linker.
Yeh MK; Liang YM; Hu CS; Cheng KM; Hung YW; Young JJ; Hong PD
J Biomater Sci Polym Ed; 2012; 23(7):973-90. PubMed ID: 21549037
[TBL] [Abstract][Full Text] [Related]
3. Cross-linking and characterisation of gelatin matrices for biomedical applications.
Kuijpers AJ; Engbers GH; Krijgsveld J; Zaat SA; Dankert J; Feijen J
J Biomater Sci Polym Ed; 2000; 11(3):225-43. PubMed ID: 10841277
[TBL] [Abstract][Full Text] [Related]
4. Functionally modified gelatin microspheres impregnated collagen scaffold as novel wound dressing to attenuate the proteases and bacterial growth.
Adhirajan N; Shanmugasundaram N; Shanmuganathan S; Babu M
Eur J Pharm Sci; 2009 Feb; 36(2-3):235-45. PubMed ID: 18952165
[TBL] [Abstract][Full Text] [Related]
5. Carbodiimide induced cross-linking, ligand addition, and degradation in gelatin.
Cammarata CR; Hughes ME; Ofner CM
Mol Pharm; 2015 Mar; 12(3):783-93. PubMed ID: 25658665
[TBL] [Abstract][Full Text] [Related]
6. Influence of Cross-Linker Concentration on the Functionality of Carbodiimide Cross-Linked Gelatin Membranes for Retinal Sheet Carriers.
Lai JY; Li YT
J Biomater Sci Polym Ed; 2011; 22(1-3):277-95. PubMed ID: 20557713
[TBL] [Abstract][Full Text] [Related]
7. Characterization of porous collagen/hyaluronic acid scaffold modified by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide cross-linking.
Park SN; Park JC; Kim HO; Song MJ; Suh H
Biomaterials; 2002 Feb; 23(4):1205-12. PubMed ID: 11791924
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity evaluation of gelatin sponges prepared with different cross-linking agents.
Ulubayram K; Aksu E; Gurhan SI; Serbetci K; Hasirci N
J Biomater Sci Polym Ed; 2002; 13(11):1203-19. PubMed ID: 12518800
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of flurbiprofen-loaded genipin cross-linked gelatin microspheres for intra-articular delivery.
Kawadkar J; Jain R; Kishore R; Pathak A; Chauhan MK
J Drug Target; 2013 Feb; 21(2):200-10. PubMed ID: 23249324
[TBL] [Abstract][Full Text] [Related]
10. Cross-linked gelatin microspheres with continuously tunable degradation profiles for renal tissue regeneration.
Serban MA; Knight T; Payne RG; Basu J; Rivera EA; Robbins N; McCoy D; Halberstadt C; Jain D; Bertram TA
Biotechnol Appl Biochem; 2014; 61(2):75-81. PubMed ID: 23692609
[TBL] [Abstract][Full Text] [Related]
11. Novel collagen scaffolds prepared by using unnatural D-amino acids assisted EDC/NHS crosslinking.
Krishnamoorthy G; Sehgal PK; Mandal AB; Sadulla S
J Biomater Sci Polym Ed; 2013; 24(3):344-64. PubMed ID: 23565652
[TBL] [Abstract][Full Text] [Related]
12. Wound closure with EDC cross-linked cultured skin substitutes grafted to athymic mice.
Powell HM; Boyce ST
Biomaterials; 2007 Feb; 28(6):1084-92. PubMed ID: 17084446
[TBL] [Abstract][Full Text] [Related]
13. Sugar cross-linked gelatin for controlled release: microspheres and disks.
Cortesi R; Nastruzzi C; Davis SS
Biomaterials; 1998 Sep; 19(18):1641-9. PubMed ID: 9839999
[TBL] [Abstract][Full Text] [Related]
14. Accelerated wound healing and its promoting effects of biomimetic collagen matrices with siderophore loaded gelatin microspheres in tissue engineering.
Ramanathan G; Thyagarajan S; Sivagnanam UT
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():455-464. PubMed ID: 30274078
[TBL] [Abstract][Full Text] [Related]
15. Control of pH alters the type of cross-linking produced by 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) treatment of acellular matrix vascular grafts.
Gratzer PF; Lee JM
J Biomed Mater Res; 2001; 58(2):172-9. PubMed ID: 11241336
[TBL] [Abstract][Full Text] [Related]
16. Crosslinked gelatin matrices: release of a random coil macromolecular solute.
Mwangi JW; Ofner CM
Int J Pharm; 2004 Jul; 278(2):319-27. PubMed ID: 15196637
[TBL] [Abstract][Full Text] [Related]
17. The effect of the cross-linking time period upon the drug release and the dynamic swelling of gelatin microspheres.
Vandelli MA; Forni F; Coppi G; Cameroni R
Pharmazie; 1991 Dec; 46(12):866-9. PubMed ID: 1818323
[TBL] [Abstract][Full Text] [Related]
18. Preparation of gelatin microspheres containing lactic acid--effect of cross-linking on drug release.
Dinarvand R; Mahmoodi S; Farboud E; Salehi M; Atyabi F
Acta Pharm; 2005 Mar; 55(1):57-67. PubMed ID: 15907224
[TBL] [Abstract][Full Text] [Related]
19. A new anti-adhesion film synthesized from polygalacturonic acid with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide crosslinker.
Lee MW; Hung CL; Cheng JC; Wang YJ
Biomaterials; 2005 Jun; 26(18):3793-9. PubMed ID: 15626427
[TBL] [Abstract][Full Text] [Related]
20. Tailoring the properties of gelatin films for drug delivery applications: influence of the chemical cross-linking method.
Coimbra P; Gil MH; Figueiredo M
Int J Biol Macromol; 2014 Sep; 70():10-9. PubMed ID: 24971558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
